New drug aims for better control of tough liver virus
NCT ID NCT07454837
Summary
This study is testing if switching people with chronic hepatitis D from their current medication to a new drug called brelovitug is safe and works better to control the virus. It will involve about 120 adults who are already being treated for the condition. The main goal is to see if the new drug can make the virus undetectable in the blood and improve liver health over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS D are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Barts Health NHS Trust
RECRUITINGLondon, E12AT, United Kingdom
-
Castle Hill Hospital
RECRUITINGCottingham, Yorkshire, HU165JQ, United Kingdom
-
Centrul Medical Unirea S.R.L
RECRUITINGIași, Lasi, 700023, Romania
-
Chelsea and Westminster Hospital
RECRUITINGLondon, SW109NH, United Kingdom
-
Clinical Hospital for Infectious and Tropical Diseases Dr. Victor Babes
RECRUITINGBucharest, 030303, Romania
-
King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
-
National Institute Of Infectious Diseases Prof. Dr. Matei Bals
RECRUITINGBucharest, 21105, Romania
Conditions
Explore the condition pages connected to this study.